FDA: Epilepsy Drug Raises Risk of Cleft Lip and Cleft Palate When Taken During Pregnancy
Taking the epilepsy drug topiramate (Topamax) during pregnancy raises the risk of oral cleft birth defects such as cleft lip and cleft palate, according to a new warning issued by the FDA.
New drug registry data show that the risk of oral birth defects is up to 16 times higher among women who took topiramate or its generic equivalents during pregnancy.
A man blinded in one eye by a chemical attack as he intervened to stop a fight has had his sight restored thanks to pioneering new stem cell treatment.